PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Clinical trials for PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR trials appear

Sign up with your email to follow new studies for PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New Bladder-Saving cancer treatment shows promise

Disease control Ongoing

This study is testing a non-surgical treatment approach for muscle-invasive bladder cancer that aims to preserve the patient's bladder. It combines chemotherapy, an immunotherapy drug (toripalimab), and radiation therapy. The main goals are to see if this combination is effective…

Matched conditions: PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Apr 04, 2026 09:21 UTC

PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Get alerted when new PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR trials appear

New Bladder-Saving cancer treatment shows promise